HUNTINGTON STATION, NY--(Marketwire - October 06, 2008) - Medivisor, Inc. (PINKSHEETS: MVSR), developer of next-generation focus driven marketing tools, announced today that it has expanded its previously announced Albumax marketing agreement. Medivisor has expanded its original agreement covering US distribution and Medivisor now has the exclusive right to distribute Albumax in Korea. Albumax, a whey protein isolate formula, makes it easy for Kidney disorder patients to reach their daily requirements of high quality protein in their diet. Medivisor anticipates consummating a distribution relationship in Korea shortly.
